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CHAPTER I
REVIEW OF LITERATURE

Stem cells have been the subject of intense interest and investigation due, in part, to
their biological properties and potential medical importance (Morrison et al., 1997).

Unfortunately, it has been exhausting for the nonspecialist to penetrate the area because of
the difficulty in culturing these delicate cells and, because of the relative challenge in isolating

these ambiguous cells from the heterogeneous population in which they reside. Stem cells are

normally ascribed with certain characteristic properties including self-renewal, differentiation

potential, asymmetric cell division, clonal regeneration of all of the different cell types that
constitute their host tissue, and they can exist in a quiescent state (Hall and Watt, 1989).

The bone marrow acts as a substratum for functionally discrete stem cells of both
hematopoietic and nonhematopoietic descent. Hematopoietic stem cells in bone marrow must

continuously provide a source ofprogenitors for red cells, monocytes, granulocytes, platelets,
and lymphocytes.

Alternatively, nonhematopoietic stem cells, often referred to as

mesenchymal stem cells, give rise to adipocytes, fibroblasts, myoblasts, chondrocytes, and
osteoblasts (Prockop, 1997). In the mid-1970's, Friedenstein e/tz/. (1976) developed a crude
procedure for separating hematopoietic and nonhematopoietic cells. Friedenstein placed

samples of whole bone marrow in plastic culture dishes and poured off the nonadherent cells
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after 4 hours. He found that the resultant adherent cells were heterogeneous in appearance
but, the most tightly adherent cells were spindle-shaped and formed foci of two to four cells

which remained dormant for 2 to 4 days after which they would multiply rapidly. After
passage several times in culture, the adherent cells became more uniformly spindle-shaped in
appearance and would differentiate into colonies that produced small deposits of bone or

cartilage.

Since the investigations ofFriedenstein, most studies on osteogenic marrow stem cells
have been conducted with the cultures derived from plastic adherence. However, several

groups of investigators since 1990 have attempted to prepare more homogeneous populations

of cells (Long et al., 1995, Simmons et al., 1991; Haynesworth et al., 1996; Waller et al.,
1995; Rickard et al., 1996). The use of isolated osteogenic marrow stem cells has several
advantages: The isolated cells are either clonal or nearly clonal, and they can be induced in

culture to express large amounts of the same bone markers and to form mineralizing colonies.
Yet, none of the protocols have yet been used in more than one laboratory, and it has not

been shown whether they isolate the same cells. Additionally, following isolation, it becomes
increasingly difficult to culture marrow stem cells since they have effectively been separated

from the nursing cells which support them, further frustrating the advancement of

investigations. Such limitations have substantially hindered the progress of studies devoted
to bone generation and development, or osteogenesis. Furthermore, the fact that bone tissue
consists of a heterogeneous multitude of cells makes the identification of molecular

mechanisms underlying bone growth a noteworthy challenge.
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Bone is a vital, dynamic connective tissue that plays critical roles in protecting and
mediating the metabolic pathways associated with mineral homeostasis, and in providing
structural support for mechanical locomotion (Babe/ al., 1994). Furthermore, it is a primary

site for hematopoiesis and has been shown to be a component of the immune system
(Horowitz et al., 1992).

Bone formation begins in utero and continues throughout

adolescence until skeletal maturity. Skeletal development is a multistep process that includes
patterning of skeletal elements, commitment of mesenchymal cells to the osteogenic and

chondrogenic lineages, and terminal differentiation of precursor cells into three specialized
cell types: osteoblasts, osteoclasts, and chondrocytes (Marcus et al., 1996). Embryonic

development of the skeleton involves two major modes which are distinct in mechanism and
function.
Intramembranous ossification is the characteristic way in which the flat bones of the

skeleton, such as the bones of the skull and face, are formed. It originates from the branchial

arches and it involves the direct formation of bone tissue by cells of the mesenchymal lineage

which have been committed to the formation of osteoblasts (Rodan et al., 1997).
Mesenchymal cells proliferate and condense into compact nodes after which some cells within
these nodes develop into capillaries and others into bone forming osteoblasts (Gilbert, 1994).
Osteoblasts secrete an uncalcified type I collagen-glycosamino-glycan matrix (osteoid) which

binds the calcium salts that are delivered to the area by the capillaries. As the nodes become

calcified, the bony spicules radiate out from the center and the entire region becomes
surrounded by compact mesenchymal cells that develop into the periosteum.
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The appendicular skeleton forms by the process of endochondral ossification. It is
derived from the somitic mesoderm and it involves the differentiation of mesenchymal cells

into chondroblasts and then to chondrocytes which synthesize and secrete the proteoglycan-

rich, type II collagen based extracellular matrix. Thus, cartilage tissue is formed which acts
as a model for the bone that follows. Endochondral ossification couples chondrogenesis with

osteogenesis to form the vertebral column and the extremities (Figure 1.1). As mesenchymal
cells differentiate into chondrocytes, the mesenchymal cells around them develop into the

periosteum. Upon forming this cartilaginous model, hypertrophic chondrocytes develop in
the center of the bone and, by secreting more fibronectin and less protease inhibitor, modify

the extracellular matrix to produce an environment which will permit invasion by blood

vessels from the periosteum. It has long been thought that as the cartilaginous model was

degraded, the hypertrophic chondrocytes died, and that the angiogenic response delivered

osteoblasts which would secrete bone matrix on the partially degraded cartilage. Recent
ultrastructural evidence indicates, however, that hypertrophic chondrocytes do not die, but

rather, may transdifferentiate into functional osteoblasts (Hunziker et al., 1987). Intrarenal
transplantation studies of isolated chondrocytes have resulted in bone formation and lend
proof to the transdifferentiation theory which states that cells expressing a cartilage

phenotype can change into cells expressing bone-associated markers (Moskalewski et al.,

1989). Striking findings have shown that hypertrophic chondrocytes also express numerous
markers which are expressed by osteoblasts as well. Some of these include osteopontin,
osteonectin, alkaline phosphatase (Marcus et al., 1996), bone sialoprotein, and parathyroid

hormone receptor, among others (Aubin et al., 1995). Thus far, it remains to be determined
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Figure LI The coupled activity of
chondrogenesis and osteogenesis during
endochondral ossification.
(Gilbert, 1994)
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whether hypertrophic chondrocytes either transdifferentiate or merely undergo further
maturational progression into bone-forming osteoblasts.
With time, the ossification front within the cartilaginous model progresses toward the

ends where the chondrocytes will proliferate prior to undergoing hypertrophy, pushing out
the ends and, forming the epiphyseal plates (Gilbert, 1994). These epiphyseal plates will form

the growth area of bone during development. Bone will continue to be added peripherally

from the internal surface of the periosteum as osteoclasts hollow out the internal region to
form the bone marrow cavity that will provide a location for further osteogenesis and
hematopoiesis. At the end of puberty, high levels of estrogen and testosterone will cause the

remaining epiphyseal plate chondrocytes to hypertrophy, ending elongation (Gilbert, 1994).
Following skeletal maturity, bone continues to remodel throughout life and to adapt
its structural properties in response to the mechanical demands placed upon it. The structural
and functional relationships observed in bone, coupled with its role in maintaining mineral

homeostasis, strongly suggest that it is an organ of optimal structural design (Skedros et al.,

1996).

The basic morphological composition of mature bone consists of a lineage of

progressively differentiating cells which produce bone and are subsequently incorporated into
the calcified bone tissue (Nijweide et al., 1986).

At the origin of this lineage are

multipotential mesenchymal cells that undergo a number of restriction steps to give rise to
progeny with more limited, including monopotential, capacities. These multipotential stem

cells initially develop into osteoprogenitor cells which are small, undifferentiated cells that
have already been committed to the osteogenic lineage (Bellows et al., 1989; McCulloch et
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al., 1990; McCulloch et al., 1991). Human osteoprogenitor cells express the STRO-1 antigen

(GronthoseZa/., 1994; Simmons et al., 1991) and are found both within the periosteum and
within cell colonies in the bone marrow along with hematopoietic cells (Prockop, 1997; Van

Vlasselaer et al., 1994; Mizuno et al., 1997). Osteoprogenitors are eventually induced to

differentiate into osteoblasts following the influence of paracrine growth factors (Long et al.,
1995; Lippiello et al., 1992; Amedee et al., 1994; Quarto et al., 1995) and hormones of the

endocrine system (Marcus et al., 1996). Some of the growth factors believed to be involved
are Transforming Growth Factor 3 (TGF-P)(Takeuchi etal., 1996;Raynale/a/., 1994),basic

fibroblast growth factor (bFGF)(Long etal., 1995), Prostaglandin-E2 (PGE2)(Centrella etal.,

1994), and Insulin-like growth factor (IGF)(Gilbert et al., 1994). These chemical factors
activate signal transduction pathways which result in the differentiation of osteoprogenitors

into bone-forming osteoblasts.
Osteoblasts adhere to the surface of bone and secrete osteoid by aposition, which is

the deposition of bone over a pre-existing bone surface (Figure 1.2). Osteoblasts are the only

cells within the osteogenic lineage to express the enzyme alkaline phosphatase on their
surface (Harris etal., 1995; Nefussi etal., 1997). Although the exact function of this enzyme

is unknown, it is believed to be responsible for hydrolyzing pyrophosphate into inorganic
phosphate which is further utilized to make calcium crystals (hydroxyapatite) (Haynesworth
et al., 1992).

Hydroxyapatite is then deposited into the osteoid to give bone its

characteristically rigid structure.
In vivo, some osteoblasts eventually become embedded within their own secretions
wherein they lose their proliferative potential and decrease their metabolic activity. At this
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point, the cell becomes known as the osteocyte, which is a cell with stellar morphology and

represents the final differentiated state of the osteogenic lineage (Yamaguchi et al., 1994).
Although imprisoned within the hard bone matrix, osteocytes remain connected with other

osteocytes and osteoblasts via cytoplasmic projections found within canaliculli networks (Van
Der Plas et al., 1994) (Figure 1.2). Since osteocytes reside within hard bone matrix, it is

believed that they are directly subjected to the mechanical loading which affects the skeleton.
Due to this fact, it is believed that osteocytes are responsible for transducing mechanical

stimuli into a more sustained cellular response (Skedros et al., 1996; Lozupone et al., 1996).

This phenomenon might occur

via an autoamplification system whereby osteocytes

recognize physical stress and respond by secreting factors which in turn relay the local

remodeling command (Van Der Plas et al., 1994).
Recent investigations have shown that osteocytes are some of the most

mechanosensitive cells in bone. Forwood et al. (1996) have shown that a single episode of
dynamic loading on bone with a magnitude of 65 Newtons increased bone formation rate
and was maximal 5-8 days post loading. Weinbaum et al. (1994) found that high frequency,
low amplitude postural strains on bone can maintain, and even increase, bone mass. They

state that the proteoglycan filled fluid annuli that surrounds the osteocytic processes within
the canaliculli could be stimulated by small fluid shear stresses. This supports the current

hypothesis that stress on bone causes the flow of fluid through the osteocytic canaliculli
network which in turn stimulates these cells to produce paracrine factors that regulate bone

metabolism (Weinbaum etal., 1994; Van Der Plas et al., 1994).
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Figure 1.2. Schematic representation of bone formation by aposition
(Alberts et al., 1994)
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Klein-Nulend et al. (1995a, 1995b) have provided evidence that osteocytes react to

pulsating fluid flow with a rapid and transient stimulation of Nitric Oxide (NO) release which
leads to an enhanced and prolonged prostaglandin (PG) E2 release. Studies run by Centrella
et al. (1994) indicate that PGE2 has direct regulatory effects on the biochemical activities of
discrete bone cell populations. They found that more differentiated bone cells could activate

and recruit less differentiated cells, by way of PGE2 production, and that these less
differentiated cells enhanced bone repair that results from cytokines released during the

inflammatory process.

Remodeling would not be complete without a cell specialized in degrading the pre
existing bone matrix. Osteoclasts are giant, polynucleated cells of the hematopoietic lineage
which are essential for executing the remodeling response.

Via osteoclastogenesis,

osteoclasts arise by the fusion of monocyte/macrophage precursors whose development is

regulated by a group of cytokines (Marcus et al., 1996). Interleukin (IL) 1, IL-3, IL-6,
erythropoietin, epidermal growth factor, and bFGF, among others, have been shown to be
required for optimal differentiation ofthe hematopoietic stem cell to the committed osteoclast

precursor (Marcus etal., 1996). Mature osteoclasts secrete acids and enzymes responsible

for the breakdown of bone. Bicarbonate, generated by carbonic anhydrase activity, is
responsible for dissolving the bone minerals (Blair et al., 1986).

Meanwhile, acid

phosphatases and collagenolytic cysteine-proteinases found within vessels destined for

exocytosis in the apical ruffled border of the osteoclast, are essential for digesting the organic
component of bone (Chambers et al., 1985). Together, osteoblasts and osteoclasts work

cooperatively in a delicate balance between bone deposition and bone resorption.
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The past few years have provided insights which have led to the realization that

endocrine and paracrine influences on bone remodeling are not mutually exclusive. Hormones

from the endocrine system have been strongly implicated in mediating bone metabolism. In

adult women, estrogen plays a critical role in maintaining bone mass by exerting a tonic
suppression of cancellous bone remodeling and maintaining remodeling balance between

osteoclastic and osteoblastic activity (Jagger et al., 1996). A remodeling imbalance results
from estrogen deficiencies which leads to increased osteoclastic activity at the expense of

impaired osteoblastic activity. Thus, the increase in osteoclastic excavation without the
concomitant increase in osteoblastic deposition has been implicated in the high incidence of
osteoporosis in post-menopausal women (Wronski et al., 1993).

Parathyroid hormone (PTH) is synthesized in the parathyroid glands in a highly
sensitive response to a falling extracellular ionized calcium activity. A fall in calcium is
detected by a calcium sensor which is a G-protein-linked cell surface protein (Marcus et al.,

1996). Messenger RNA for the receptor is most abundantly found in the parathyroid glands,
but is also found in the kidneys and in the thyroid gland where the hormone might mediate

the Ca2+-sensitive secretion of calcitonin from the thyroid C-cells.

Parathyroid hormone increases the number and activity of osteoclasts in bone. It
induces osteoclasts to mobilize and degrade the bone matrix and, by doing so, raises
circulating levels of Ca2+ (Holtrop et al., 1979). However, PTH receptors have not been

demonstrated on osteoclasts and there is no evidence that the hormone exerts a direct
biological effect on isolated osteoclasts (Marcus et al., 1996).

Osteoblasts and their

precursors are sensitive to the hormone and may serve as intermediaries in PTH-mediated,
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osteoclastic bone resorption by secreting paracrine factors which directly stimulate
osteoclasts.

Calcitonin, synthesized and secreted by the thyroid gland in response to high
circulating levels of Ca2+ (Miyauchi et al., 1990), dampens bone resorption by directly

targeting osteoclasts. Calcitonin binding sites are, in fact, the only peptide hormone receptors
unequivocally resident on osteoclasts. Osteoclast exposure to calcitonin is followed by an

increase in intracellular Ca2+ activity and generation of cyclic AMP (Marcus et al., 1996).
Within seconds, osteoclasts contract and become immobile due to changes in the microtubule
and microfilament arrangements within the cytoskeleton. Thus, calcitonin and parathyroid

hormone act by opposing each other through a system of checks and balances to mediate and

control mineral homeostasis.

Along with endocrine and paracrine signals, autocrine factors are critical for mediating

and maintaining bone metabolism. Nitric Oxide (NO) has not only been shown to be an

important autocrine factor involved in the osteocytic response to mechanical stress, but it
dramatically alters osteoclastic bone resorption as well (Marcus et al., 1996). NO is located
in the ruffled membrane and is induced when osteoclasts contact the skeletal matrix. NO is

produced by osteoclasts via NO synthase and directly targets the osteoclast itself.
Interestingly, NO inhibits osteoclast spreading (Holtrop et al., 1991). Thus, it acts much like

calcitonin in inhibiting bone resorption (Marcus et al., 1996).

Recently, various novel growth factors have been discovered which appear to play

crucial roles in bone development and maintenance. Genes encoding for the bone
morphogenic proteins (BMPs) are critical during morphogenesis and body axis determination
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(Gilbert et al., 1994). During embryonic limb development in mice, BMPs are expressed at

sites of cartilage and bone development (Robey et al., 1985). These BMP’s, in turn,

participate in the signaling cascade required for limb morphogenesis.
Core-binding factor 1 (Cbfal), which belongs to the rwnZ-domain gene family, is
restrictively expressed during fetal development (Mundlos et al., 1997). In mammals, three

r//A7/-domain genes have been found (Cbfal/Pebp2aA, Cbfa2/Pebp2aB, and Cbfa3/Pebp2aC)

which contain a 128 amino acid-long DNA binding domain, runt, which is homologous with
the Drosophila melanogaster pair-rule gene runt (Komori et al., 1997; Ducy et al., 1997).

They form heterodimers with the cotranscription factor Cbfb/Pebp2b and their
heterodimerization is required for their DNA-binding capacity in vitro (Ducy et al., 1997).
Data reviewed so far strongly suggest that Cbfal is an essential transcription factor required

for bone formation and, more specifically, for osteoblast differentiation (Ducy et al., 1997).
Komori et al. (1997)deleted the Cbfal gene in mice by homologous recombination.

The homozygous Cbfal'7' mice died soon after delivery due to an inability to breathe. Upon
detailed analysis, it was found that the mice completely lacked the intramembranous bones

of the skull and the endochondral bone in the rest of the skeleton. Histochemical analysis of
the Cbfa'' mice has shown that osteoblasts are absent and that osteoclasts are smaller than
normal (Otto et al., 1997).

Cbfal may regulate expression of early markers for osteoblast differentiation, as well

as osteocalcin expression.

Cbfal stimulates osteoblast-specific transcription of the

osteocalcin gene via the osteoblast-specific c/.s-acting element, OSE2, in the osteocalcin

promoter (Geoffroy et al., 1998). Osteocalcin is the only gene to be expressed in osteoblasts
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and in no other extracellular matrix-producing cell type (Towler et al., 1994; Ducy et al.,
1996). The human osteocalcin gene is localized on chromosome 1 and it is approximately 1.2

kb with four exons that predict a 125 amino acid-long protein (Marcus et al., 1996). Due to

the highly specific nature of osteocalcin expression, its promoter has been intensely
scrutinized and investigations have led to the characterization of the “osteocalcin box”. The
osteocalcin box contains a binding site for Msx-1 and Msx-2 (homeodomain proteins) which

have been found to be synthesized by osteoblastic cells (Marcus et al., 1996).
Osteocalcin is made by osteoblasts and it is considered to be a marker of osteoblastic

function as well as a coupler for the osteoblast-osteoclast interaction during remodeling
(Marcus et al., 1996). It has also been shown to be an important factor for the induction of

the osteoclastic phenotype. Since osteocalcin has a high and relatively specific affinity for
apatite, it has been proposed as a specific regulator of the length of the mineral crystals in

bone (Kesterson et al., 1993). Furthermore, osteocalcin has been reported to be involved in
osteoclast recruitment. Investigations on osteocalcin’s function have shown that osteocalcin-

deficient bone particles are not readily resorbed (Ducy et al., 1995). Though recent analysis
supports the role of osteocalcin in regulating bone growth in vivo, further studies are required
before its effects on osteoblasts, osteocytes, and osteoclasts can be verified.

Although many aspects of mature osteoblast function have been clarified in recent

years, there is little information about the regulation of the early stages of osteoprogenitor
differentiation. A primary limitation to these studies has been the difficulty in identifying and

establishing an unambiguous and homogeneous population of osteoprogenitor cells.

Complicating the situation is the fact that, upon isolation, these primary precursor cells are
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fragile and not very permissive to many of the standard manipulation protocols employed in

cellular and molecular biology. In attempt to delineate the regulatory mechanisms that
mediate osteoprogenitor differentiation, several model systems have been developed (Hicok

etal., 1998; Jaenisch etal., 1988; No et al., 1996). Some of these model systems have been
obtained from cell lines derived from malignant bone or bone marrow tumors yet, although

important information has been obtained with these systems, the malignant transformations
usually alter the molecular and cellular phenotypes substantially.

The aforementioned cell lines are all employed in hopes that some of the fundamental
mechanisms underlying normal osteogenesis may be determined, however, the abnormalities

incurred by such malignant transformations preclude full confidence that results resemble the
characteristics of wild type osteoprogenitor cells.

An invaluable tool for studying

development and other physiological processes is the precise control of cell proliferation and
differentiation. Therefore, the establishment of a conditionally immortalized cell line of

osteoprogenitor cells would greatly enhance the ability to study stage-specific cellular
interactions and paracrine regulation of osteogenesis (Hofmann et al., 1992). No et al.
(1996) have recently established a system allowing the conditional induction of specific genes

with the insect molting hormone ecdysone. The steroid hormone ecdysone has been shown

to trigger metamorphosis in Drosophila and its genomic effects were detected, in part, as
influencing chromosomal puffing within minutes of hormone addition.

A benefit for

transferring ecdysone responsiveness to mammalian cells is that it takes advantage of a
naturally evolved steroid-inducible system whose lipophilic compounds enable efficient

penetration into all tissues (No et al., 1996). Ecdysteroids have short half-lives and favorable
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pharmacokinetics which expedite clearance and prevent storage. Additionally, the fact that

they are neither toxic, teratogenic, nor known to affect mammalian physiology, make them
ideal reagents for use in conditionally immortalized cultured cells.

In the first part of this study we intend to develop a means for extracting osteogenicspecific cells (osteoprogenitors, osteoblasts, and osteocytes) from mice, establishing suitable
culturing conditions for these cells, and characterizing the developmental stages down the
osteogenic lineage. In the second part, we propose a highly efficient technique for isolating

human osteoprogenitor cells from femoral bone marrow by using the STRO-1 antibody

(Developmental Studies Hybridoma Bank) conjugated with magnetic beads. We also offer
conclusive evidence that osteoprogenitors reside within the STRO-1 positive cell fraction of
the human bone marrow and we indicate species-specific differences between human and

mouse osteoprogenitors. Furthermore, we attempt to conditionally immortalize human

osteoprogenitor cells by introducing the ecdysone-inducible expression system employing the
transfection techniques of calcium-phosphate precipitation and electroporation.
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CHAPTER II

Isolation and Characterization of Murine Osteogenic Cells
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ABSTRACT

Femoral bone cells from adult female mice were isolated and fractionated into 3
discrete cell populations that represent the various stages of the osteogenic lineage. Upon

separation and cultivation, osteoprogenitors, osteoblasts, and osteocytes were monitored and
characterized for distinct morphological differences. Further in vitro characterization of

differentiation was evaluated by following the sequential expression of the membrane-bound

enzyme alkaline phosphatase. Although specific surface markers have not been identified for
murine osteoprogenitors, it is known that they reside within the adherent, low-density (ALD)

cell fraction of the bone marrow stroma. These alkaline phosphatase negative, small (~10
//m), round cells are highly proliferative, forming clusters (<50 cells) and colonies (>50 cells)
before spreading and

differentiating into alkaline phosphatase positive osteoblasts and

radiating outward from the central cell aggregates.

Homogeneous cultures of osteoblasts and osteocytes were established by sequential
digestion of calcified bone tissue with collagenase followed by separation with an anti-alkaline

phosphatase monoclonal antibody. Both cell types regained their distinctive morphology
within 2-3 days post extraction. In fact, osteocytes assumed their characteristic stellate
morphology and extended thin cytoplasmic projections toward each other suggestive ofthose
situated within canaliculli networks in calcified bone.
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INTRODUCTION

In mammals, it is generally accepted that osteogenesis proceeds by fundamentally

common mechanisms. In fact, most research on osteogenesis and bone remodeling has been

conducted using murine models and the results are believed to be representative and indicative

of human osteogenesis. Many investigations have already characterized a formal series of
stages through which an osteogenic cell must pass as it progresses down the osteogenic

lineage. As with all other mammals, murine osteogenesis begins with the osteoprogenitor
stem cell, proceeds into the functional osteoblast cell, and concludes at the terminally
differentiated osteocyte. Although a few of the genes involved in this process have been

discovered, most have yet to be identified.
A major impedance to the in vitro study of osteogenesis is the difficulty in establishing

separate and morphologically distinct osteogenic cell cultures from the heterogeneous
population found within bone and bone marrow. In this study, we propose a series of
techniques for extracting and isolating osteoprogenitors, osteoblasts, and osteocytes from

mouse femoral marrow and calcified bone tissue. Furthermore, we have characterized the
discrete morphological stages of the osteogenic cell lineage and report some striking speciesspecific differences between murine and human osteoprogenitor differentiation.
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MATERIALS AND METHODS

Isolation and Cultivation of Osteoprogenitor Cells
Bone marrow stromal cells were isolated from the femurs of 2-month-old female

BALB/c mice. Briefly, femurs were excised aseptically and the ends of the bones were
removed. The bone marrow was flushed out using 5 mL of Phosphate Buffered Saline (PBS,

pH 7.2) through a 21 gauge needle attached to a 5 mL syringe. The released cells were
dispersed into a single-cell suspension and aliquoted into two 13x100 mm sterile tubes
containing anhydrous EDTA (10.5 mg Na2) (Terumo Venoject). The contents were shaken
briefly, transferred into two disposable, sterile 15 mL centrifuge tubes (Fisherbrand, Florence,
KY), and centrifuged at 300 x g for 10 minutes at 20°C. The supernatant was discarded and

cells were resuspended in 5 mL of Dulbecco’s modified Eagle medium (D-MEM)

supplemented with 10% fetal calf serum (FCS), 1 mM sodium pyruvate, 2 mM glutamine,
50 U/ml penicillin, 50 pg/ml streptomycin and

100 pM non-essential amino acids (all

reagents purchased from Atlanta Biologicals, Norcross, GA)(from now on referred to as
complete medium).

Next, the cell suspensions were subjected to equilibrium-density

centrifugation (density=1.086±0.001g/mL @ 20°C)(Ficoll; Atlanta Biologicals, Norcross,

GA) and the resultant mononuclear, low-density cells (i.e., those cells present at the Ficollmedium interface) were counted with a hemocytometer and treated to 4 hours of plastic
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adherence to remove nonadherent cells. The final concentration of adherent cells was

determined by subtracting the number of nonadherent cells from the total mononuclear, lowdensity cell concentration. The resultant adherent cells were cultivated on 35 mm dishes, 4

mm wells, and in 16 mm wells either on plastic, on a thin coating of solidified rat tail type I
collagen at 5 pg per cm2, or within 12% type I collagen gel. Cultures were incubated in the
presence of complete culture medium at 37 °C in 5% CO2.

Extraction and Isolation of Osteoblasts and Osteocytes
Femurs were obtained aseptically as described above, flushed with PBS to remove
marrow, and dissected free of periostea. The calcified tissue was minced and a mixture of

osteoblasts and osteocytes was extracted by sequential collagenase (Life Technologies, Grand
Island, NY) digestion.

Briefly, minced bone was incubated in collagenase at a final

concentration of 2 mg/mL in PBS at 37°C for intervals of 1,2,4, and 8 hours (respectively

called OCY I, II, III, and IV) with agitation every 30 minutes. Following each digestion

interval, the supernatant was collected, centrifuged at 300 x g for 15 minutes at 20°C,
resuspended in serum-free medium, and the cells were seeded (at a concentration of 2.5-6.5

x 105 cells/cm2) for one hour onto 35mm dishes coated with the alkaline phosphatase-specific
MAb, B4-50 (lOpg/mL) (Mayo Clinic, Rochester, MN) and rotated gently every 15 minutes.

Nonadherent osteocytes and immune adherent osteoblasts were separated and cultivated in
complete culture medium at 37°C in 5% CO2.
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Alkaline Phosphatase Activity
Osteogenic differentiation was assessed by the alkaline phosphatase chromogenic reaction

(Narisawa et al., 1990). Cells were fixed on days 3, 5, 8, 10 and 14 with 10% formalin in
PBS for 10 minutes at +4°C. The cells were then washed two times with 0.2AY Tris buffer,
pH 8.9. The reaction mixture, prepared fresh, consisted of 0.1% napthol AS-MX phosphate
(Sigma BioSciences, St.Louis, MO) and 0.3% fast violet B salt (Sigma BioSciences, St.Louis,

MO) in 0. LA/ Tris buffer, pH 8.9. The fixed cells were incubated in the presence of the

reaction mixture for 30-40 minutes at 37°C then viewed under a brightfield microscope (IMT2 Olympus inverted research microscope)
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RESULTS

Osteoprogenitor Cells
Adherent, low-density cultures consisted of small (~10/zm), round cells that
proliferated rapidly immediately following extraction. Within 3 days post-extraction, the

isolated cells proliferated into patches, or clusters (10-50 cells), which further developed into

large colonies (>50 cells) in a matter of 5-7 days. Furthermore, within a week of cultivation,
the cells began to differentiate into spread and elongated, alkaline phosphatase positive cells

which radiated out from the central cell aggregates (Figure II.la and b).

Figure II.2

represents the data gathered from four trials run in duplicates throughout a two week time
span each of the differentiation of putative osteoprogenitors into osteoblast-like cells.

Putative osteoprogenitors cultivated on 4 mm wells, 16 mm wells, and 35 mm dishes
displayed different degrees of colony-forming efficiency with greater levels of cell division

being detected as the surface area of the culture flasks increased. In fact, neither colony

forming efficiency nor differentiation were detected at all in the 4mm wells. Furthermore,
both alkaline phosphatase activity and differentiation occurred nearly twice as quickly in the

35 mm dishes as opposed to the 16mm wells (7days vs. 14+days for maximal differentiation,

respectively).
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Figure II.l. a. Aspects of small osteoprogenitor clusters in the process of differentiating into
alkaline phosphatase positive cells (stained red) after 7 days in culture. Original xl50. b.
Fully mature alkaline phosphatase positive osteoblasts after 14 days in culture. Original x
200.
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Proliferation Rate of Alkaline Phosphatase
Positive Osteoblasts

Figure H.2. Data gathered over a period of two weeks for the
proliferation rate of differentiated adherent low-density cells on plastic.
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Osteoprogenitors seeded onto a thin coating of solidified type I collagen displayed the

same behavior as cells plated on plastic surfaces. Neither variations in proliferation nor
differentiation were observed between the two culture conditions. However, cells cultivated

in 12% type I collagen gel lost all proliferative and differentiative potential. Interestingly,
when these osteoprogenitors could avoid the collagen gel by becoming situated on a collagen-

free surface, they reacquired their characteristic behavior patterns to form clusters.
From all of the trials in which differentiation ensued it became evident that mouse
osteoprogenitors follow the central dogma of cell development in which cells are believed to

proliferate first, then differentiate. Accordingly, alkaline phosphatase expression was detected

at low activity only after the osteoprogenitors began spreading and elongating into osteoblast

like morphology. Alkaline phosphatase activity could be detected as early as day 5 post
extraction and increased gradually until it began to decline again after about 12 days post

extraction. Following the decline in alkaline phosphatase activity, cells would lose some of
the characteristic osteoblast morphology and some cells would die. However, most cells

simply seemed to enter the Go phase of the cell cycle.

Osteoblasts and Osteocytes

Immune adherence produced pure cultures of osteoblasts which displayed maximal
levels of alkaline phosphatase activity. Within 24 hours post-extraction, osteoblasts began
to resume their natural morphology by spreading and proliferating.

Osteoblasts were

monitored and subcultured for 1 month post-extraction. Alkaline phosphatase activity

persisted for the first 2 weeks post-extraction but began to subside between weeks 2 and 3.
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Purified osteoblast degeneration resembled that observed for the osteoblasts produced from

the osteoprogenitor trials in which cell death and quiescence resulted from prolonged tissue
culturing.

Similarly, isolated osteocytes resumed their natural, stellate morphology within 24
hours post-extraction (Figure II.3a and b). Shortly following extraction, osteocytes extended

cytoplasmic projections toward each other reminiscent of the networks found within bone
canaliculli. As expected, longer periods of collagenase digestion yielded greater percentages

of osteocytes with a concomitant decrease in osteoblast numbers. These results produced

nearly pure cultures of osteocytes within the OCY IV digestion intervals. These pure
osteocyte cultures retained their characteristic stellate morphology for 10 days after which

their cytoplasmic projections would shorten and lose some of their discrete borders and

edges.
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L
Figure II.3. a. Femoral bone cells after 4 hours digestion with collagenase I and following
10 days in culture. Stellar-shaped osteocytes are seen extending cytoplasmic projections
toward alkaline phosphatase positive osteoblasts. Original x 300. b. Isolated osteocytes after
12 hours digestion with collagenase I and removal of osteoblasts with the monoclonal
antibody, B4-50. Neighboring osteocytes are seen connected by cytoplasmic bridges.
Original x 400.
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DISCUSSION

It has been reported previously that osteoprogenitor cells reside within the

nonadherent, low-density subpopulation of the bone marrow (Long et al., 1995). Our

analysis indicates, however, that the adherent, low-density cell fraction of the bone marrow
displayed characteristics expected of osteoprogenitor cells. Cultivated adherent cells initially

appeared small and round yet proliferated rapidly then differentiated into osteoblast-like,

alkaline phosphatase positive colonies.

Furthermore, other researchers claim that

osteoprogenitors require the administration of essential factors such as dexamethasone and

type I collagen in order to differentiate into functional osteoblasts in vivo (Mizuno et al.,

1997). We found otherwise. None of our cultures were dependent on factors other than the
ones found within our complete culture medium in order to develop into monolayers of

osteoblasts. It remains to be determined, however, whether factors present within our

medium may have driven osteoprogenitor differentiation. That is, the particular type of fetal
calf serum used in our studies may contain essential factors which were not present in other

investigations.
Additionally, osteoprogenitors embedded within 12% collagen gel lost all proliferative

and differentiative potential and those cultured over a thin layer of solidified collagen did not
display elevated activity levels when compared to cells maintained on plastic alone. The fact
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that collagen gel coating inhibited osteoprogenitor cellular activity would be expected since
it would be unnecessary for an osteogenic stem cell to expend energy and differentiate into
a bone forming osteoblast in the presence of a preexisting three-dimensional bone matrix. In

other words, when found in excess, collagen may act as a growth inhibitor for
osteoprogenitors since the presence ofthis protein would indicate adequate bone production.

Alternatively, the normal resulting activity by osteoprogenitors seeded onto a thin layer of

solidified collagen would also make intuitive sense since an open, one-dimensional layering

of collagen would simply be translated as a bone surface which is devoid of, and in need of,

osteoblasts.
Osteoprogenitors grown on different size culture flasks exhibited greater degrees of

proliferation and differentiation with increasing surface area. Although no minimal cell

concentration threshold required for optimal cell division and differentiation could be

determined conclusively, it was apparent that the inherent differences in cellular activity could

be attributed to cell numbers (mean cell density for 16mm wells was 2 x 105cells/cm2 as
opposed to 6 x 104cells/cm2 for 35mm dishes however, overall, 35mm dishes contained more

cells than 16mm wells).

It appears as if when plated at decreasing concentrations in

accordance with a smaller surface area, osteoprogenitors lose their capacity for growth. A
decrease in cell numbers may result in the decrease of a secreted growth factor by other
stromal cells which, when present at a critical concentration, induces osteoprogenitor

proliferation and differentiation.

Results from the osteocyte and osteoblast extraction experiments produced purified
cultures which can be used to further study the mechanical induction of bone remodeling. As
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expected, longer digestion intervals resulted in greater concentrations of osteocytes with a

concomitant decrease in osteoblasts since osteocytes are situated further into the calcified
bone tissue within lacunae. Thus, all three cells types have been extracted successfully and

have been made available for further experimentation. Worth mentioning is the fact that,
although plastic adherence provided us with a bone marrow cell subtype which was capable

of differentiating into functional osteoblasts, a pure culture ofmouse osteoprogenitors cannot
be prepared by this method alone. Despite our efforts to remove nonadherent, high-density
cells, the resultant osteoprogenitor cultures consisted of heterogeneous populations of bone

marrow-specific cells. Further modification of the protocols would have to be made before
a truly purified culture could be produced. Specifically, pure cultures would be difficult to

achieve unless a surface marker for murine osteoprogenitors is discovered and an antibody

is generated against it.
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CHAPTER HI
Immunomagnetic Isolation of Osteoprogenitors from Human
Bone Marrow Stroma

Work supported by: Ohio Board of Regents Research Challenge Program
and Sigma Xi, The Scientific Research Society
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ABSTRACT

We report her the efficient isolation of human bone marrow osteoprogenitors using
magnetic beads coated with a mouse monoclonal antibody recognizing the STRO-1 antigen
(Simmons etal., 1991). Osteoprogenitors accounted for 100% of the STRO-1 positive cell
population. Upon long term culture, osteoprogenitors differentiated down the osteoblastic

lineage as evidenced by their increased expression of alkaline phosphatase and their
production of osteocalcin. Human osteoprogenitors assumed a spread morphology in tissue

culture. Upon differentiation, they first expressed alkaline phosphatase on their surface before
they began proliferating as phenotypically recognizable osteoblasts. This observation conflicts
with previous studies that have characterized human osteoprogenitors as highly proliferative

cells that form colonies prior to differentiating into osteoblasts (Long etal., 1995). The ability
to isolate human osteoprogenitors with high efficiency will substantially advance

investigations on osteogenesis and bone remodeling.

Key words:

osteoprogenitor, human, isolation, magnetic beads, differentiation
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INTRODUCTION

The proteins present in the bone extracellular matrix (ECM) are synthesized by
osteoblasts, which are cells of mesenchymal origin. Osteoblasts produce the type I collagen-

glycosaminoglycan (GAG) matrix in which they are subsequently incorporated. Beside
collagen type I and GAG, osteoblasts produce osteocalcin, a protein which is not secreted by
any other ECM-synthesizing cell type (Towler et al., 1994; Ducy et al., 1995). Expression

of osteocalcin is under control of Cbfa-1, a transcription factor belonging to the Cbfa family
of proteins, which are homologs of Runt, a Drosophila pair-rule gene product (Gergen etal.,

1985; Ducy eta/., 1997; Komori etal., 1997; Otto eta/., 1997). Osteoblasts also express the

membrane-bound enzyme alkaline phosphatase at high levels (Herbertson et al., 1997).
Although much has been learned in recent years about the regulation of differentiation

in mature osteoblasts, there is less information about the regulation of earlier stages of cell
differentiation within the osteoblastic lineage. It is now generally accepted that osteoblasts

arise by differentiation from multipotential progenitor cells within the bone marrow stroma
that also are capable of committing to other mesenchymal lineages, including fibroblasts,

myoblasts, chondrocytes, and adipocytes (Aubin et al., 1993; Triffit etal., 1996; Owen c/a/.,
1988). However, progress in understanding the direct precursors of osteoblasts, the
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osteoprogenitors, has been hampered by the small number of molecular markers available

(Aubineta/., 1996).
Several in vitro systems have been developed in order to understand the cellular and

molecular mechanisms regulating osteoprogenitors and osteoblasts differentiation. Initially,

osteoblast-derived cell lines were obtained from malignant bone tumors. However, due to
their irreversibly transformed phenotype, these cell lines cannot be used to study normal
osteoblast differentiation (Hassager et al., 1992; Okazaki et al., 1995). Mouse bone marrow

stromal cell lines have also been established, which exhibit different phenotypes and
differentiation potential down the osteoblastic lineage (Benayahu et al., 1991; Fried et al.,

1996). However, it is unclear whether the stages of differentiation in these cell lines
correspond exactly to those ofhuman osteoblast differentiation. Recently, stable transfections
of immortalizing, non-transforming genes such as the Simian Virus 40 Large T antigen (S V40

LTAg), the polyoma virus LTAg gene, or the adenovirus El A gene have been used to
facilitate the production of cell lines from various mouse and human somatic tissues (Linder
et al., 1990; Spelsberg et al., 1995). However, a problem associated with the introduction of

immortalizing genes into cells is that these genes can alter normal cellular morphology and

physiology (Brinster et al., 1984; Ridley et al., 1988). This problem theoretically can be
overcome by using mutant conditional immortalizing genes. The technique allows the

generation of continuously proliferating cell lines capable of differentiation after inactivation
of the immortalizing gene. For example, the SV40 mutant temperature-sensitive (ts) gene

tsA58 has been used in the generation of a variety of conditionally immortal somatic cell lines

(Jate/cz/., 1989, 1991; Chambers etal., 1993; Morgan et al., 1994; Okuyama
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1995)

including mouse and human osteoprogenitors (Dennis et al., 1996; Hicok et al., 1998).

However, upon long-term culture, these cells may not conserve their ability to differentiate.

This may be due to cumulative changes induced by the Large T antigen over time, that

prohibit reversal of cellular immortalization, as shown recently in other systems (Ewald et al.,
1996).
Another model system employs primary human or rodent bone marrow stromal cells

isolated by density gradient separation followed by plastic adherence (Friedenstein, 1976).

The non-adherent fraction of marrow stromal cells has also been studied (Long et al., 1995).
In all cases, some of the isolated stromal cells were able to differentiate into osteoblasts.

However, bone marrow consists of a contiguous population of phenotypically and
functionally diverse cell groups that collectively regulate and support hematopoiesis and

osteogenesis. A network of adipocytes, endothelial cells and macrophages coexists intimately
with cells responsible for maintaining the mechanical identity of the calcified bone tissue. The

osteoprogenitor concentration in bone marrow has been estimated at one cell in one hundred

thousand (Haynesworth e/ al., 1992; Rickard et al., 1996; Cheng et al., 1994, Kasseme/a/.,
1991). Thus, due to the diversity of the stromal elements, an inability to identify an

unambiguous and homogenous population of osteoprogenitors has considerably hindered the

progress of scientific investigation.
Furthermore, studies have shown that the STRO-1 positive fraction of the human

bone marrow consists of cells capable of forming mineralized matrix and producing the bone-

specific protein osteocalcin (Gronthos et al., 1994). However, the claim that the STRO-1
positive subpopulation of the human bone marrow has not been universally accepted as

36

containing the osteoprogenitor stem cell. Further investigations have to be conducted in

order to confidently assure that the STRO-1 antigen is undeniably expressed on human bone
marrow osteoprogenitor cells.
In the present study, we report a highly efficient method for extracting and isolating
human bone marrow osteoprogenitors, using density gradient centrifugation and a specific
antibody conjugated to magnetic beads . The antibody is known to recognize an surface

antigen, STRO-1, expressed by a subset of human bone marrow stromal cells (Simmons et
al., 1991). After a period of culture of 21 days, the isolated putative osteoprogenitors
differentiated down the osteoblastic lineage as evidenced by their strong alkaline phosphatase

activity and their production of the osteoblast-specific protein, osteocalcin.
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MATERIALS AND METHODS

Human subjects:
Samples of trabecular bone were obtained aseptically from the hip of 40 human

volunteers during joint replacement surgery. Samples were collected at Miami Valley
Hospital, Dayton, OH, during a period of one year, and after the subjects’ informed consent.

Isolation of bone marrow mononucleated cells:
Immediately following surgery, the bone samples were placed in 10 ml Dulbecco’s

modified Eagle medium (D-MEM) supplemented with 10% fetal calf serum (FCS), 1 mM

sodium pyruvate, 2 mM glutamine, 50 U/ml penicillin, 50 pg/ml streptomycin and 100 pM
non-essential amino acids. The samples were finely minced with scissors. Remaining bone
fragments were removed by passing the suspension through sterilized gauze. The resulting
cell suspension was centrifuged at 200 x g, washed once with phosphate-buffered saline (PBS,

pH 7.2) and resuspended in 10 ml of supplemented D-MEM. To isolate mononucleated cells,
the cell suspension was carefully layered on

top of 10 ml of a Ficoll solution

(density=l ,086±0.001g/mL @ 20°C) and centrifuged at 400 x g for 30 minutes at 20°C. The
mononucleated cells were recovered from the medium-Ficoll interphase, resuspended in 2 ml
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of supplemented D-MEM and proceeded for immunopurification. All reagents were

purchased from Atlanta Biologicals, Atlanta, GA.

Preparation of magnetic beads/antibody conjugates.

Dynabeads M-450 (Dynal, Lake Success, NY) were washed and coated with the
mouse monoclonal anti-STRO-1 antibody (University of Iowa Hybridoma Bank) (Simmons

etal., 1991) essentially according to the manufacturer’s instructions. Briefly, 5 pg of STRO-

1 antibody were added to 107 Dynabeads in a final volume of lOOpL of 0.5M Borate buffer,
pH 8.0, and mixed gently by pipetting. The mixture was placed in a 15 ml sterile centrifuge

tube (Fisherbrand, Florence, KY) and incubated for 24 h at 4°C on a rotary shaker (190
strokes/min). Following incubation, the coated beads were placed in a magnet (Dynal MPC-

10) for 60 seconds and drained of the supernatant. They were washed twice for 5 minutes at

4°C, then overnight at 4°C, using a rotary shaker. As a washing buffer, we used PBS

supplemented with BSA (100 mg/ml), pH 7.4. Chemicals were purchased from Sigma, St

Louis, MO.

Immunomagnetic isolation of human osteoprogenitors'.
Antibody-conjugated Dynabeads were added directly to the cell samples at a final

concentration of 4-10 beads /cell and a volume of 4 ml supplemented D-MEM. The cellbeads mixtures were placed in a sterile 15 ml centrifuge tube (Fisherbrand, Florence, KY) and
gently shaken overnight at room temperature. The cell-beads mixtures were then placed in
a magnet (Dynal MPC-10) for 60 seconds to recover the STRO-1 positive cells (Figure III. 1).
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The supernatant was discarded and the STRO-1 positive cells washed gently with PBS

supplemented with BSA (100 mg/ml), pH 7.4. The cells were resuspended in 1 ml PBS and
placed on a shaker for 5 minutes at room temperature. This washing protocol was repeated
three times after which the cells were resuspended in supplemented D-MEM and plated at a

density of 104 cells per 35 mm dish, in 2 ml supplemented D-MEM. The cells were incubated
in a humidified incubator at 37°C and 5% CO2.

Alkaline phosphatase activity.

Differentiation of osteoprogenitors was assessed using cytochemistry for alkaline
phosphatase according to Narisawa et al. (1990). Isolated and cultivated STRO-1 positive

cells were fixed in situ on culture days 5, 8, 10 and 14 with 10% formalin in PBS for 10
minutes at 4°C. The cells were then washed twice with 0.2 M Tris buffer, pH 8.9. The

reaction mixture, prepared fresh, consisted of 0.1 % naphtol-AS-MX phosphate and 0.3 %
fast violet B salt in 0.1 M Tris buffer, pH 8.9. All reagents were purchased from Sigma, St

Louis, MO. The fixed cells were incubated in presence of the reaction mixture for 30-40
minutes at 37°C. Following incubation, they were washed with distilled H2O, viewed under
a bright field microscope (IMT-2 Olympus microscope) and the number of cells positive for

alkaline phosphatase counted.
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Figure ULl. Schematic illustration of the immunomagnetic protocol
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Immunofluorescence'.

STRO-1 positive cells were cultivated for 21 days and assayed in situ for the
expression of osteocalcin. The cell culture medium was removed and the cells washed briefly
with PBS. The cells were fixed in 4% paraformaldehyde in PBS (pH 7.2) for 10 minutes at

room temperature. After two washes with PBS, the cells were incubated for 20 minutes in

1% horse serum in PBS, then they were exposed for 1 hour to a 1/500 dilution of a mouse
anti-human osteocalcin MAb (Takara Biomedicals, Japan). Following incubation and two

washes with PBS, the cells were incubated with the second antibody (fluorescein anti-mouse

IgG, Vector Laboratories, Burlingame, CA) for 1 hour at room temperature in the dark. After
two washes with PBS, the cells were visualized with a fluorescence microscope (BH-2

Olympus biological fluorescence microscope). As anegative control, the human breast cancer

cell line, MDA-231, was assayed for the expression of osteocalcin.

Reverse transcriptase-polymerase chain reaction

Total RNA was extracted from freshly isolated STRO-1 positive cells, and from
STRO- 1 positive cells after 21 days of culture. We used RNAzol reagent and the protocol
provided by the manufacturer (Tel-Test, Friendswood, TX). Total RNA samples were treated

with RNase-free DNase (Promega, Madison, WI) to eliminate any genomic DNA present.
Single-strand cDNA was obtained after reverse transcription of 1 pg of total RNA using

oligo-dT primers and Superscript II reverse transcriptase (Gibco, Grand Island, NY). Two

pi of the resulting cDNA were selectively amplified for 40 cycles (94°C for 1 min, 60°C for
1 min, 72°C for 2 min) with primers specific for mouse and human Cbfa-1, and human
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osteocalcin. The primers selected for Cbfa-1 were(5'-GAGGGCACAAGTTCTATCTGGA-3'
forward sequence) and (5-GGTGGTCCGCGATGATCTC-31 reverse complement). These

primers were chosen according to Ducy et

and Geoffroy et al. (1998). The

resulting PCR fragment is 336 bp long. The primers selected for human osteocalcin were
devised according to the sequence reported by Celeste et al., (1986). They were (5GCCCTCACACTCCTCGCCC-3' forward sequence) and (5'-CACACACCTCCCTCCTGG-

3' reverse complement). The resulting PCR product is a fragment of 206 bp. As negative

controls, we performed PCR onRT reaction products obtained without reverse transcriptase.

43

RESULTS

Following purification, osteoprogenitors were plated and monitored for differentiation
and/or proliferation. Interestingly, human osteoprogenitors remained in isolation and did not

develop into clusters or colonies of cells (Figure III.2). Moreover, they seemed to remain
quiescent for a period of 8-10 days before any activity was recorded. Instead of proliferating

into colonies, human osteoprogenitors spread and assumed the osteoblastic morphology prior
to undergoing cell division (Figure III.3).

This characteristic pattern of differentiation

originated at individual cells then spread from the central loci to other cells. Only after

spreading and elongation was complete within clusters of 4 or more cells was any

proliferation observed in these cultures.

Furthermore, expression of alkaline phosphatase was not detected in these cultures

until the cells began assuming the osteoblastic phenotype. In fact, we found that achieving
maximal expression levels of alkaline phosphatase enzyme was strikingly correlated with the
onset of division.
Upon differentiating into mature osteoblasts, proliferation ensued vigorously until

monolayers of pure alkaline phosphatase positive osteoblasts reached confluence within 2-3
weeks (Figure III.4). On day 21, mature osteoblasts were assayed for the presence of
osteocalcin by immunofluorescence. Figures III.5a and c are photographs of individual
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osteoblasts taken under phase contrast microscopy following immunofluorescence. Figures
in. 5b and d are respective photographs of the same cells under fluorescence microscopy. As

evidenced by the photographs, osteocalcin can be found within compartments in the
cytoplasm of differentiated STRO-1 positive cells. Figures III.5e and f are photographs of
MDA-231 cells following immunofluorescence under phase contrast and fluorescence

microscopy, respectively.
Results for the RT-PCR trial were inconclusive. We did not detect the presence of

either osteocalcin or Cbfa-1 mRNA within differentiated cells.
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Figure DL2. Human bone marrow STRO-1 positive cells immediately
following isolation using immunomagnetic isolation. Yields consisted of
100% STRO-1 antigen expressing cells. Original x800.

46

Figure HL3. Alkaline phosphatase expression following human bone
marrow STRO-1 positive cell differentiation. Cells assume a spread,
elongated morphology and express high levels of alkaline phosphatase
prior to proliferating. Original x300.
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Figure IIL4. Monolayers of alkaline phosphatase positive osteoblast-like
cells (stained red) following human bone marrow STRO-1 positive cell
differentiation. Original x300.
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b

Figurein.5. Anti-osteocalcin immunofluorescence images. Images a and c
were taken under phase-contrast microscopy of differentiated STRO-1
positive cells after 21 days in culture. Images b and d were taken under
fluorescence microscopy for the corresponding cells. Images e and f are of
MDA-231 cells under phase contrast and fluorescence microscopy,
respectively, used as a negative control. All images x 200 magnification.
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DISCUSSION

The establishment of an in vitro model system for studies on osteoprogenitors is the
focus of this report. Previous investigations have established the expression of the STRO-1

antigen on human bone marrow osteoprogenitors (Gronthos etal., 1994). The investigators

demonstrated that the differentiation of STRO-1 positive human osteoprogenitor cells into

functional osteoblasts could be assessed by monitoring their induction of alkaline phosphatase
expression, by the production of the bone-specific protein osteocalcin, and by the formation

of a mineralized matrix (hydroxyapatite) (Gronthos et al., 1994). However, the cultures

obtained by their means were not pure.

In the present study, we have developed a highly efficient means for extracting and

isolating a pure osteoprogenitor cell population from human bone marrow. By coating
magnetic beads with the STRO-1 monoclonal antibody and by extracting the cells with a
magnet, we have successfully established pure primary cultures of osteoprogenitors, as 100%

of the cells isolated developed into alkaline phosphatase positive osteoblasts. Additionally,
we have characterized the differentiation of the human osteoprogenitor cell by monitoring its
progressive expression of alkaline phosphatase down the osteogenic lineage and by

confirming their identity through the expression of osteocalcin among mature STRO-1
positive cells.
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Our observations show that human bone marrow osteoprogenitors are small, round

cells that have already been committed to the osteogenic lineage.

Moreover, human

osteoprogenitors begin to express low levels of alkaline phosphatase en route to becoming

mature osteoblasts. We found that these osteoprogenitor cell cultures must first differentiate
into alkaline phosphatase positive osteoblasts prior to undergoing cell division. In fact,
maximal levels of alkaline phosphatase were concomitant with the onset of proliferation. Our
observations and those made recently by Hicok et al (1998) are in agreement with this
finding. However, these results conflict with previous studies by Long et al. (1995) which

state that human osteoprogenitors are highly proliferative cells which form clusters and

colonies consisting of >50 cells prior to differentiating.
The finding that osteoprogenitor differentiation originates at distinct loci and then
spreads out towards neighboring cells indicates that once one osteoprogenitor cell initiates

differentiation into the osteoblast-like morphology, it may begin to secrete paracrine factors
which induce other osteoprogenitor cells to follow. Our results indicate that a likely candidate

would be osteocalcin since this protein is expressed by osteoblasts only and is locally secreted

into the immediate environment. However, further studies must be conducted in order to

determine which other factor(s) might be responsible for inducing this paracrine-associated
differentiation response.

Unfortunately, RT-PCR did not yield expected results for the expression of
osteocalcin or Cbfa-1 RNA within mature STRO-1 positive cells.

The fact that the

osteocalcin protein was detected within mature STRO-1 positive cells would imply that its

respective RNA should also be found within the cells. This leads us to believe that the
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conditions under which the RT-PCR was conducted were not optimal for our assay. Further
modifications are required in order to develop an ideal system by which to run the reaction.

Recent investigations have revealed many of the molecular mechanisms involved in

regulating the functional and structural properties of bone yet, with every question answered,
many more arise.

A major limitation to such investigations has been the difficulty in

identifying a homogeneous and unambiguous population of osteoprogenitor cells that can
readily be purified and induced to differentiate. We report an efficient means for overcoming

such limitations. Ultimately, it would be necessary to determine how tissue development,
mechanical input, cellular response, and the material properties of the tissue are organized in

space, time, and function in order to maintain bone homeostasis. Such fundamental obscurities
require further clarification before a truly comprehensive understanding of bone can be
achieved.
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CHAPTER IV
CONCLUSION

Bone is

a mechanically optimized organ system whose evolution reflects the

functional demands placed upon it. Although it serves as a structural framework, bone is

far from being an inert substance. On the contrary, bone tissue plays essential roles as a

hematopoietic factory and as a mediator of mineral homeostasis. Furthermore, unlike any
other composite tissue or organ system, bone is constantly being broken down, modified, and

rebuilt in a process known as remodeling. This process is regulated and maintained by
various external and internal signals, including signals from the central nervous system.

Considering the prolific nature of osteoprogenitors, it is not surprising to learn that this stem
cell mediates the early stages of bone remodeling. Osteoprogenitors must do so on a
continual basis since bone is constantly being broken down and rebuilt.

The general

mechanisms by which this occurs are similar for all mammals. However, as we have shown,
there are, in fact, some distinct species-specific differences with respect to osteoprogenitor

behavior. Although a number of reservations remain in the field about whether the human

osteoprogenitor expresses the STRO-1 antigen, we have shown that this is indeed the case.
In our studies, 100% of the STRO-1+ fraction of the human bone marrow exhibited the

characteristics expected of osteoblast precursors. Yet, we did not detect the antigen on
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murine osteoprogenitors.

This implies that some fundamental genetic diversities exist

between the two species. Additionally, we have shown that murine osteoprogenitors are
highly proliferative cells which form clusters then colonies of 50 or more clones before they

undergo differentiation. In fact, such cellular progression underlies a long accepted dogma
of cell biology which dictates that cells proliferate then differentiate. In humans, this is not

so. Our results indicate that human osteoprogenitors are not conspicuously proliferative, but
rather, supply the bone-forming machinery by first differentiating into alkaline phosphatase

positive preosteoblasts and then proliferating into monolayers of functional osteoblasts.

Recently, Hicok et al. (1998) published an article stating that the sequence of rat osteoblast

differentiation differs significantly from the sequence observed in human bone marrow stromal
cells, suggesting that important species differences exist. Their findings lend support to our

observations on the species-specific characteristics of osteoblast differentiation.

In summary, we have succeeded in extracting, culturing, and characterizing the cells
which represent the three distinct stages of osteogenesis. We have also developed a highly

efficient means for purifying human bone marrow osteoprogenitor cells by using

immunomagnetic isolation.

Furthermore, we have characterized these cells and have

conclusively proven the expression of the STRO-1 antigen on human bone marrow

osteoprogenitors.
Although extensive studies have been conducted on the stimulation and signal

transduction pathways associated with bone remodeling, much remains to be determined

before a truly comprehensive understanding can be achieved. Thus far, it is well accepted
that the complexities of remodeling occur through several general phases including
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quiescence, activation, resorption, reversal, and formation.

Recent investigations have

revealed many of the molecular mechanisms involved in regulating the functional and

structural properties ofbone yet, with every question answered, many more arise. Ultimately,
it would be necessary to determine how tissue development, mechanical input, cellular

response, and the material properties of the tissue are organized in space, time, and function

in order to maintain bone homeostasis. Further clarification of such fundamental obscurities

would inevitably result in the advancement of therapeutic techniques for crippling bone
diseases such as osteoporosis and for the loss of bone integrity due to disuse, such as that

experienced in hypogravity environments.

Additionally, a better understanding of the

molecular mechanisms for bone regeneration would substantially enhance and accelerate bone
repair in the future.

In order to facilitate the investigations on osteogenesis, we have also endeavored to
establish a conditionally immortalized human osteoprogenitor cell line. We attempted to do

so with the ecdysone-inducible expression system developed by No et al. (1996). We have

prepared a plasmid construct (pIND/LTAg) that contains the SV40 Large T antigen (LTAg)

gene (Hofmann et al., 1992) which is transcribed upon activation of an ecdysone response
element (E/GRE) by a heterodimeric receptor.

Ecdysone is an insect-specific steroid

hormone which induces molting and metamorphosis by influencing chromosomal puffing. A

benefit for transferring ecdysone responsiveness to mammalian cells is that it takes advantage
of a naturally evolved steroid-inducible system whose lipophilic compounds enable efficient

penetration into all tissues (No et al., 1996). Ecdysteroids have short half-lives and favorable

pharmacokinetics which expedite clearance and prevent storage. Additionally, they are
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neither toxic, teratogenic, nor known to affect mammalian physiology. These characteristics
make them ideal candidates for utilization in the conditional immortalization of human
osteoprogenitors.

The pIND/LTAg plasmid was successfully constructed. All evaluations indicated that
the plasmid should function according to expectations. However, co-transfection of human
bone marrow STRO-1 positive cells were not successful by either calcium phosphate

precipitation or electroporation. Calcium phosphate precipitation proved much too stressful

for the delicate bone marrow stem cells. Calcium phosphate exposure was varied in order to
limit its toxicity to the cells however even the minimal incubation time induced cell death.

Although electroporation did not kill the stem cells directly, it became obvious that
the technique was too invasive for the cells to handle. Unlike the STRO-1 positive cells

which were not electroporated, those which were shocked did not differentiate or proliferate
following transfection. As reported in chapter III, immunomagnetically isolated STRO-1

positive cells began to differentiate and proliferate after 8-10 days in culture. Electroporated
cells would neither differentiate nor proliferate but rather, would enter the Go stage of the cell

cycle indefinitely.
We have determined that the difficulty in immortalizing the STRO-1 positive cells can
be attributed to their stem cell characteristics. To begin with, the STRO-1 positive cell

fraction of the bone marrow accounts for only 1 in 100,000 cells. Such low cell numbers

decrease the success rate for plasmid introduction. Furthermore, being stem cells, STRO-1

positive cells are extremely fragile cells which do not respond very well to the techniques
employed in immortalization. Additionally, as evidenced by their slow growth rate following
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isolation, STRO-1 positive bone marrow stem cells display low levels of DNA replication

which further complicate the introduction ofthe plasmid constructs into the genomes. Finally,
not only is single transfection of stem cells difficult but, co-transfection dramatically decreases

the probability that immortalization will be successful.
Essentially, the odds against co-transfection were substantial however we determined

that the benefits in producing a conditionally immortalized STRO-1 positive stem cell line

outweighed the risks associated with the challenge. Recently, there has been a growing

interest in using marrow stromal cells as vehicles for both gene and cell therapy. Implanted
marrow stromal cells into poorly healing bone could possibly enhance the repair process

(Prockop, 1997). Marrow stromal cells locally injected were shown to promote repair of

surgical incisions in rabbit knee cartilage, and cells in ceramic beads were shown to promote
bone healing in an animal model (Caplan et al., 1994). Furthermore, introducing genes for

secreted proteins into stem cells and then infusing the cells systemically so that they return to
the marrow and secrete the therapeutic protein is another possible application for a

conditionally immortalized stem cell line. Alternatively, one could encapsulate cells secreting

a therapeutic protein into some inert material that allows diffusion of the proteins but not the

cells themselves (Prockop, 1997). An additional application is to infuse the conditionally

immortalized cell line systemically under conditions in which the cells will not only repopulate
bone marrow, but will also give rise to progeny for the repopulation of other tissue such as
lung, bone, cartilage, and perhaps even brain (Pereira et al., 1996).

Ultimately, the benefits for a conditionally immortalized osteoprogenitor cell line
continue beyond the scope of this report. However, of particular importance for developing
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conditionally immortalized cell lines is the fact that they can be induced to proliferate and
expand in culture yet, upon administration into the human body, would behave as normal cells
do naturally. This would limit the complications that could arise from such therapeutic

procedures.

A significant portion of our research focused on stem cell biology. Stem cells are
notorious for being difficult to isolate and cultivate. Such characteristics are at the basis for
why, even though interests are high, there remains a very low number of researchers which
specialize in stem cell investigations. However, we hope that studies such as this one will

ultimately help advance the studies on such cells for they lie at the foundation of most

developmental processes. Establishing a thorough understanding of their properties and
functions will eventually lead to quicker, more efficient, and less invasive therapeutic

techniques which will better the conditions of not only bone repair, but human healthcare in

general.
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